Table 2.
Angiographic and procedural characteristics
| Variables | DM n = 81 | Non-DM n = 173 | P-value |
|---|---|---|---|
| Vessel | |||
| LM/LAD/LCX/RCA | 2/38/14/27 | 4/97/29/43 | 0.498 |
| Type B2/C lesions | 68 (84%) | 133 (76.9%) | 0.196 |
| Lesions | |||
| Lesion lengths, mm | 25.81 ± 10.82 | 23.86 ± 11.02 | 0.187 |
| Ostial location | 9 (11.1%) | 18 (10.4%) | 0.865 |
| Angulation > 45° | 34 (42%) | 58 (33.5%) | 0.209 |
| Moderate-severe calcification | 16 (19.8%) | 30 (17.3%) | 0.727 |
| Bifurcation | 19 (23.5%) | 49 (28.5%) | 0.449 |
| Repeat DES | |||
| Type (EES/ZES) | 37/44 | 69/104 | 0.414 |
| Number of stents (n) | 1.61 ± 0.92 | 1.75 ± 0.89 | 0.263 |
| Stent length (mm) | 27.21 ± 10.92 | 24.65 ± 10.83 | 0.082 |
| Stent diameter (mm) | 2.86 ± 0.41 | 2.93 ± 0.39 | 0.234 |
Data are presented as mean ± SD or n (%)
LM left main coronary artery, LAD left anterior descending coronary artery, LCX left circumflex artery coronary artery, RCA right coronary artery, EES Everolimus Eluting Stent, ZES Zotarolimus Eluting Stent